Cargando…
Brolucizumab: Evaluation of Compassionate Use of a Complex Anti-VEGF Therapy
OBJECTIVE: To report a consecutive series of compassionate, off-label use of intravitreal brolucizumab as a rescue therapy for complex, non-responsive macular edema. This report delineates primary diagnosis, indications for treatment, adverse events, and visual and anatomic outcomes after intravitre...
Autores principales: | Murray, Julianna E, Gold, Aaron S, Latiff, Azeema, Murray, Timothy G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702983/ https://www.ncbi.nlm.nih.gov/pubmed/34983996 http://dx.doi.org/10.2147/OPTH.S339393 |
Ejemplares similares
-
Disaster Preparedness Impact In A Complex Ophthalmology Practice: A Review Of Patients Receiving Intravitreal Injections
por: El Hamichi, Sophia, et al.
Publicado: (2019) -
Brolucizumab—another anti-VEGF or beyond
por: Sharma, Ashish, et al.
Publicado: (2020) -
Long-Term Followup Comparing Two Treatment Dosing Strategies of (125)I Plaque Radiotherapy in the Management of Small/Medium Posterior Uveal Melanoma
por: Murray, Timothy G., et al.
Publicado: (2013) -
Clinical Findings and Genetic Expression Profiling of Three Pigmented Lesions of the Optic Nerve
por: de Alba, Manuel A., et al.
Publicado: (2015) -
One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents
por: Coney, Joseph M, et al.
Publicado: (2023)